³ÉÈËBÕ¾ Announces Voluntary Corrective Action for the Single-Use Ligating Device Dec 5, 2025 ³ÉÈËBÕ¾, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States Dec 5, 2025 Learning Opportunities Key for ³ÉÈËBÕ¾ Canada Employees Dec 2, 2025 Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer Dec 2, 2025 ³ÉÈËBÕ¾ Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business Nov 11, 2025 ³ÉÈËBÕ¾ Unveils Corporate Strategy Nov 7, 2025 ³ÉÈËBÕ¾ Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment Oct 31, 2025 ³ÉÈËBÕ¾ to Highlight Versatile ENT Portfolio of Hybrid Endoscopy and Advanced Imaging at AAO, ARS Annual Meetings Oct 8, 2025 ³ÉÈËBÕ¾ and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the ³ÉÈËBÕ¾ EndoTherapy Portfolio Oct 6, 2025 ³ÉÈËBÕ¾ Launches the OLYSENSEâ„¢ Platform with CADe/AI Solution in the U.S. Sep 30, 2025 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
³ÉÈËBÕ¾, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States Dec 5, 2025
Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer Dec 2, 2025
³ÉÈËBÕ¾ Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business Nov 11, 2025
³ÉÈËBÕ¾ Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment Oct 31, 2025
³ÉÈËBÕ¾ to Highlight Versatile ENT Portfolio of Hybrid Endoscopy and Advanced Imaging at AAO, ARS Annual Meetings Oct 8, 2025
³ÉÈËBÕ¾ and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the ³ÉÈËBÕ¾ EndoTherapy Portfolio Oct 6, 2025
